Title of article
N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents
Author/Authors
Mohammadi-Farani, Ahmad Department of Pharmacology - Toxicology and Medical Services - Faculty of Pharmacy - Kermanshah University of Medical Sciences, Kermanshah , Heidarian, Neda Students Research Committee - Kermanshah University of Medical Sciences, Kermanshah - Department of Medicinal Chemistry - Faculty of Pharmacy - Kermanshah University of Medical Sciences, Kermanshah , Aliabadi, Alireza Department of Medicinal Chemistry - Faculty of Pharmacy - Kermanshah University of Medical Sciences
Pages
6
From page
487
To page
492
Abstract
A new series of N-(5-Mercapto-1,3,4-thiadiazol-2-yl)-2-phenylacetamide derivatives (3a- 3j) were synthesized via an amidation reaction using EDC and HOBt in acetonitrile solvent at room temperature condition. Chemical structures were characterized by 1H NMR, IR and MS spectroscopic methods and related melting points were also determined. The anticancer activity was evaluated using MTT procedure in-vitro. All compounds were tested against SKNMC (Neuroblastoma), HT-29 (Colon cancer) and PC3 (Prostate cancer) cell lines. According to the toxicological data, none of the synthesized derivatives exerted superior activity than doxorubicin as reference drug. Derivatives with Ortho chlorine (compound 3d), meta methoxy (compound 3h) and meta fluorine (compound 3b) substituents on the phenyl ring exhibited the
best cytotoxic activity against SKNMC (IC50 = 4.5 ± 0.035 μM), HT-29 (IC50 = 3.1 ± 0.030 μM) and PC3 (IC50 = 12.6 ± 0.302 μM) cell lines respectively.
Keywords
Synthesis , 1,3,4-Thiadiazole , Anticancer , Amidation
Journal title
Astroparticle Physics
Serial Year
2014
Record number
2416486
Link To Document